Stelac Advisory Services’s AbbVie ABBV Stock Holding History

Stelac Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,051	Closed	-$142K	–	150
2022 Q3	$142K	Buy	1,051 +8	+0.8%	+$1.15K	0.06%	140
2022 Q2	$160K	Buy	+1,043	New	+$159K	0.06%	141
2022 Q1	–	Sell	-1,040	Closed	-$141K	–	173
2021 Q4	$141K	Buy	+1,040	New	+$123K	0.04%	163
2021 Q3	–	Sell	-1,590	Closed	-$179K	–	215
2021 Q2	$179K	Sell	1,590 -10	-0.6%	-$1.13K	0.04%	221
2021 Q1	$173K	Sell	1,600 -1,426	-47%	-$153K	0.06%	157
2020 Q4	$324K	Buy	+3,026	New	+$291K	0.08%	137

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stelac Advisory Services's ABBV Position: Q4 2022 in Review

Stelac Advisory Services sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 1,051 shares — an estimated $142K sold.

Stelac Advisory Services first reported a position in ABBV in Q4 2020 and held it in 6 quarters. The position peaked at $324K in Q4 2020. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Stelac Advisory Services reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
Stelac Advisory Services sold 1,051 AbbVie shares in Q4 2022, an estimated $142K.
Stelac Advisory Services first reported a position in AbbVie in Q4 2020 and held it in 6 quarters.
Stelac Advisory Services's AbbVie position peaked at $324K in Q4 2020.
3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Stelac Advisory Services's 13F filing for Q4 2022, filed 14 Feb 2023.